文献速递青光眼

检测频率对光学相干断层扫描(OCT)与OCT血管成像检测青光眼进展所需时间的影响

Effect of Testing Frequency on the Time to Detect Glaucoma Progression With Optical Coherence Tomography (OCT) and OCT Angiography.
PubMed 文献 · Am J Ophthalmol · 2022-09-10

这项回顾性观察性队列研究纳入98例青光眼患者的156只眼,平均随访3.5年,利用线性回归测量视网膜周围毛细血管密度(cpCD)与视网膜神经纤维层(cpRNFL)纵向变化率,并通过计算机模拟评估不同检测频率下检测到进展所需时间。结果显示检测频率越高,检出统计学显著进展所需时间越短但不成比例;每年检测2次与3次之间差异较小,作者认为每年2次检测或可提供足够信息。

要点

  • 每年检测1、2、3次时,80%的cpRNFL年丢失-1 µm的眼分别在6.3、5.0、4.2年后被检出。
  • cpCD检测进展略早于cpRNFL,但两者检测进展的能力相当。

核心结论

  • cpRNFL与cpCD在检测青光眼进展方面能力相当。
  • 检测频率从每年2次增至3次时,检出进展所需时间仅有小幅变化,作者认为每年检测2次或可在临床环境中为OCT或OCTA检测进展提供足够信息。

研究设计与样本

  • 回顾性、观察性队列研究,纳入98例青光眼患者的156只眼,平均随访3.5年。
  • 纳入至少完成4次OCT与OCTA检测的参与者,采用线性回归测量cpRNFL厚度与cpCD的纵向变化率。
  • 利用变异性估计通过计算机模拟重建真实世界cpRNFL与cpCD数据,评估不同丢失速率与不同检测频率下检测进展所需时间。

主要发现

  • 随着检测频率增加,检测到统计学显著cpRNFL与cpCD负斜率所需时间缩短,但不成比例。
  • cpCD检测进展略早于cpRNFL。
  • cpRNFL年丢失-1 µm时,每年检测1、2、3次分别在6.3、5.0、4.2年后检出80%眼的进展。

临床怎么用

  • 作者认为,鉴于检测频率从每年2次增至3次时检出进展所需时间仅有小幅变化,每年检测2次或可在临床环境中为OCT或OCTA检测进展提供足够信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine how the frequency of testing affects the time required to detect statistically significant glaucoma progression for circumpapillary retinal nerve fiber layer (cpRNFL) with optical coherence tomography (OCT) and circumpapillary capillary density (cpCD) with OCT angiography (OCTA). DESIGN: Retrospective, observational cohort study. METHODS: In this longitudinal study, 156 eyes of 98 patients with glaucoma followed up over an average of 3.5 years were enrolled. Participants with 4 or more OCT and OCTA tests were included to measure the longitudinal rates of cpRNFL thickness and cpCD change over time using linear regression. Estimates of variability were then used to re-create real-world cpRNFL and cpCD data by computer simulation to evaluate the time required to detect progression for various loss rates and different testing frequencies. RESULTS: The time required to detect a statistically significant negative cpRNFL and cpCD slope decreased as the testing frequency increased, albeit not proportionally. cpCD detected progression slightly earlier than cpRNFL. Eighty percent of eyes with a cpCD loss of -1%/y were detected after 6.0, 4.2, and 4 years when testing was performed 1, 2, and 3 times per year, respectively. Progression in 80% of eyes with a cpRNFL loss of -1 µm/y was detected after 6.3, 5.0, and 4.2 years, respectively. CONCLUSIONS: cpRNFL and cpCD are comparable in detecting progression. As there were only small changes in the time to detect progression when testing increased from 2 to 3 times per year, testing twice per year may provide sufficient information for detecting progression with either OCT or OCTA in clinical settings.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mahmoudinezhad G, Moghimi S, Proudfoot JA, et al. Effect of Testing Frequency on the Time to Detect Glaucoma Progression With Optical Coherence Tomography (OCT) and OCT Angiography. Am J Ophthalmol. 2022. PMID: 36096181. doi:10.1016/j.ajo.2022.08.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。